Suggestions
Benjamin Gannon
Head of Int’l Access & Policy at Guardant Health; Member of the Board, EUCOPE
Professional Background
Benjamin Gannon is a highly accomplished International Corporate Affairs and Access Leader known for his extensive expertise in the biotech and pharmaceutical industries. Over the years, Benjamin has cultivated a deep understanding of the complex interplay between corporate affairs, government relations, and access issues across multiple markets. His deep-seated knowledge enables him to navigate the intricacies of policy environments while advocating for patient access and corporate accountability.
In his role as the Head of Access & Policy, International at Guardant Health, Benjamin spearheads strategic initiatives that seek to enhance patient access to cutting-edge diagnostics and therapies, ensuring that innovative solutions reach those in need. This position highlights his commitment to improving healthcare outcomes on a global scale.
Before joining Guardant Health, Benjamin shaped policy and advocacy strategies at prominent organizations, including Myriad Genetics, Vertex Pharmaceuticals, and Essity. His strategic insight during his tenure as Vice President for International Access, Policy & Advocacy at Myriad Genetics resulted in significant advancements in patient outreach and governmental engagement initiatives. At Vertex Pharmaceuticals, Benjamin led initiatives in government affairs that fostered relationships with key stakeholders, which were critical in impacting legislation and access policies.
Throughout his career, Benjamin's strategic acumen has been coupled with an impressive ability to manage crises and engage with media effectively, ensuring that the voices of patients and stakeholders consistently resonate in governmental discussions.
Education and Achievements
Benjamin’s educational background is as robust as his professional resume. He studied MSc in Biotechnology at the prestigious Imperial College London, where he developed a strong scientific foundation that underpins his work in the industry. Building on this foundation, he further sought to expand his leadership and strategic capabilities by completing the Programme for Executive Development at IMD Business School. Additionally, his pursuit of financial insights in business performance at the Stockholm School of Economics equipped him with the analytical skills necessary for navigating the corporate landscape successfully.
Further enhancing his leadership profile, Benjamin completed a study in Portfolio Leadership at The Wharton School, where he honed his ability to assess and manage diverse projects and initiatives effectively. His commitment to continuous professional development underscores his dedication to staying in tune with evolving industry trends and practices.
Notable Contributions and Leadership Roles
Benjamin's experience is punctuated by significant leadership roles within various renowned organizations where he has made a lasting impact. His contributions to the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) as a Board Member reflect his influence in shaping policy discussions that focus on fostering innovation within the pharmaceutical sector in Europe.
Earlier in his career, Benjamin held several senior positions, including Senior Director of Government Affairs, International at Gilead Sciences and Executive Director of Government Affairs for Europe at Johnson & Johnson. In these roles, he established effective communication channels with stakeholders, advocating for policies that support patient access to vital medications.
Additionally, his prior experience as a Senior Consultant at Ernst & Young and a Senior Research Analyst at The Weinberg Group allowed him to refine his analytical and consulting skills, which he applies to now lead initiatives that deal with corporate responsibility, stakeholder engagement, and systemic change within the healthcare sector.
Community Engagement and Advocacy
Benjamin is also passionate about engaging with the community and advocating for corporate social responsibility. He believes in the integral role that corporations have in society and pushes for initiatives that align corporate goals with societal outcomes. His comprehensive understanding of global health challenges informs his advocacy work, placing patients at the heart of every initiative he leads.
Benjamin’s strategic vision and profound understanding of international markets will continue to propel him forward as a key player in the biotech and pharmaceutical sectors, ensuring that innovation in healthcare is accessible to all. His insights on policy development and stakeholder engagement will undoubtedly play a significant role in shaping the future of patient access initiatives.
Achievements
Ben has been instrumental in engaging stakeholders and influencing public policy to enhance patient access to innovative therapies.
Questions
How did Benjamin Gannon develop his expertise in international corporate affairs and access within the biotech and pharmaceutical industry?
What specific strategies has Benjamin implemented to improve patient access as Head of Access & Policy at Guardant Health?
How has Benjamin's education at prestigious institutions like Imperial College London and IMD Business School shaped his career trajectory in the industry?
What notable initiatives and contributions has Benjamin made during his time as Vice President at Myriad Genetics?
In what ways has Benjamin engaged with the community to promote corporate social responsibility initiatives and patient advocacy?
